Literature DB >> 8040131

Tobramycin and daptomycin disposition when co-administered to healthy volunteers.

J R Woodworth1, E H Nyhart, J D Wolny, G L Brier, H R Black.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8040131     DOI： 10.1093/jac/33.3.655

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  5 in total

1.  Serum bactericidal activities of high-dose daptomycin with and without coadministration of gentamicin against isolates of Staphylococcus aureus and Enterococcus species.

Authors:  C Andrew DeRyke; Christina Sutherland; Bo Zhang; David P Nicolau; Joseph L Kuti
Journal:  Antimicrob Agents Chemother       Date:  2006-11       Impact factor: 5.191

Review 2.  Suppression of premature termination codons as a therapeutic approach.

Authors:  Kim M Keeling; Dan Wang; Sara E Conard; David M Bedwell
Journal:  Crit Rev Biochem Mol Biol       Date:  2012-06-07       Impact factor: 8.250

Review 3.  Daptomycin.

Authors:  Caroline Fenton; Gillian M Keating; Monique P Curran
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 4.  Daptomycin: a review of its use in the management of complicated skin and soft-tissue infections and Staphylococcus aureus bacteraemia.

Authors:  Philip I Hair; Susan J Keam
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 5.  Daptomycin: a cyclic lipopeptide antimicrobial agent.

Authors:  LilyAnn Jeu; Horatio B Fung
Journal:  Clin Ther       Date:  2004-11       Impact factor: 3.393
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.